Trademark Overview
On Thursday, October 16, 2025, a trademark application was filed for XYNAPSE with the United States Patent and Trademark Office. The USPTO has given the XYNAPSE trademark a serial number of 99446868. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 16, 2025. This trademark is owned by Immudex ApS. The XYNAPSE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Preparations for pharmaceutical purposes, preparations for medical purposes, chemical-pharmaceutical preparations, diagnostic preparations for medical purposes, reagents for medical and veterinary purposes; vaccines; analytical preparations for medical purposes, including for each of the above preparations for the development or analysis of vaccines, immunotherapeutics and cellular therapy, including cancer vaccines and immunotherapeutics, borrelia vaccines, tuberculosis vaccines, HIV vaccines and CMV vaccines, T-cell treatments, or for use in connection with cancer therapy or other therapy, for the analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissues, and infectious diseases, and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring
Chemical products for diagnostic, industrial and scientific purposes; diagnostic reagents for diagnostic and scientific purposes; research reagents for scientific and diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes; diagnostic kits for scientific and diagnostic purposes; assays for research and diagnostic purposes; biochemical reagents; analytical preparations for scientific purposes related to vaccines and immunotherapeutics, cancer vaccines, borrelia vaccines, tuberculosis vaccines, HIV vaccines, CMV vaccines and other vaccines, or for use in connection with therapy and immunotherapy, including cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissues, and for analysis of infectious diseases and autoimmunity, and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; chemical reagents
